Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSB-001 in Stage 2 and 3 Neurotrophic Keratitis
NCT04909450Phase 2Completed
- Sponsor
- Claris Bio
- Start
- Aug 2021
- Primary completion
- May 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 2 trial of dHGF in neurotrophic keratitis (NK), sponsored by Claris Bio. Started Aug 2021; status: completed.
02
Drugs
dHGF
03
Conditions
neurotrophic keratitis (NK)
Beyond the preview
Go deeper on NCT04909450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04909450.